These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 27191497
1. microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway. Chen Y, Jiang J, Zhao M, Luo X, Liang Z, Zhen Y, Fu Q, Deng X, Lin X, Li L, Luo R, Liu Z, Fang W. Oncotarget; 2016 Jul 05; 7(27):41306-41319. PubMed ID: 27191497 [Abstract] [Full Text] [Related]
2. miR-374a-CCND1-pPI3K/AKT-c-JUN feedback loop modulated by PDCD4 suppresses cell growth, metastasis, and sensitizes nasopharyngeal carcinoma to cisplatin. Zhen Y, Fang W, Zhao M, Luo R, Liu Y, Fu Q, Chen Y, Cheng C, Zhang Y, Liu Z. Oncogene; 2017 Jan 12; 36(2):275-285. PubMed ID: 27270423 [Abstract] [Full Text] [Related]
3. Dual roles of miR-374a by modulated c-Jun respectively targets CCND1-inducing PI3K/AKT signal and PTEN-suppressing Wnt/β-catenin signaling in non-small-cell lung cancer. Zhao M, Xu P, Liu Z, Zhen Y, Chen Y, Liu Y, Fu Q, Deng X, Liang Z, Li Y, Lin X, Fang W. Cell Death Dis; 2018 Jan 23; 9(2):78. PubMed ID: 29362431 [Abstract] [Full Text] [Related]
4. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer. Yang H, Lin J, Jiang J, Ji J, Wang C, Zhang J. Cell Cycle; 2020 Nov 23; 19(21):2939-2954. PubMed ID: 33044899 [Abstract] [Full Text] [Related]
5. microRNA-382 suppresses the progression of pancreatic cancer through the PI3K/Akt signaling pathway by inhibition of Anxa3. Wan X, Guo D, Zhu Q, Qu R. Am J Physiol Gastrointest Liver Physiol; 2020 Sep 01; 319(3):G309-G322. PubMed ID: 32463333 [Abstract] [Full Text] [Related]
6. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY, Jiao DM, Wu YQ, Chen J, Wang J, Tang XL, Mou H, Hu HZ, Song J, Yan J, Wu LJ, Chen J, Wang Z. Oncotarget; 2016 Apr 05; 7(14):18247-61. PubMed ID: 26919096 [Abstract] [Full Text] [Related]
7. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN. Ramírez-Moya J, Wert-Lamas L, Santisteban P. Oncogene; 2018 Jun 05; 37(25):3369-3383. PubMed ID: 29353884 [Abstract] [Full Text] [Related]
8. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways. Wei ZJ, Tao ML, Zhang W, Han GD, Zhu ZC, Miao ZG, Li JY, Qiao ZB. Int J Clin Exp Pathol; 2015 Jun 05; 8(5):4481-91. PubMed ID: 26191138 [Abstract] [Full Text] [Related]
9. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1. Xu YY, Wu HJ, Ma HD, Xu LP, Huo Y, Yin LR. FEBS J; 2013 Aug 05; 280(16):3768-79. PubMed ID: 23731275 [Abstract] [Full Text] [Related]
10. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway. Li Y, Ma X, Wang Y, Li G. Biomed Pharmacother; 2017 Sep 05; 93():435-443. PubMed ID: 28666210 [Abstract] [Full Text] [Related]
11. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Meng J, Zhang XT, Liu XL, Fan L, Li C, Sun Y, Liang XH, Wang JB, Mei QB, Zhang F, Zhang T. Cell Signal; 2016 Nov 05; 28(11):1673-82. PubMed ID: 27449264 [Abstract] [Full Text] [Related]
12. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer. Liu F, Chen S, Yu Y, Huang C, Chen H, Wang L, Zhang W, Wu J, Ye Y. Gene; 2022 Apr 20; 819():146240. PubMed ID: 35114275 [Abstract] [Full Text] [Related]
13. MicroRNA-708 targeting ZNF549 regulates colon adenocarcinoma development through PI3K/AKt pathway. Zhao Z, Qin X. Sci Rep; 2020 Oct 07; 10(1):16729. PubMed ID: 33028966 [Abstract] [Full Text] [Related]
14. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway. Zang M, Zhang B, Zhang Y, Li J, Su L, Zhu Z, Gu Q, Liu B, Yan M. PLoS One; 2014 Oct 07; 9(11):e112908. PubMed ID: 25398131 [Abstract] [Full Text] [Related]
15. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer. Sun R, Liu Z, Han L, Yang Y, Wu F, Jiang Q, Zhang H, Ma R, Miao J, He K, Wang X, Zhou D, Huang C. FASEB J; 2019 Apr 07; 33(4):5411-5424. PubMed ID: 30698996 [Abstract] [Full Text] [Related]
16. MicroRNA-381 inhibits lung adenocarcinoma cell biological progression by directly targeting LMO3 through regulation of the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition. Xuan YW, Liao M, Zhai WL, Peng LJ, Tang Y. Eur Rev Med Pharmacol Sci; 2019 Oct 07; 23(19):8411-8421. PubMed ID: 31646571 [Abstract] [Full Text] [Related]
17. MiR-328-3p inhibits cell proliferation and metastasis in colorectal cancer by targeting Girdin and inhibiting the PI3K/Akt signaling pathway. Pan S, Ren F, Li L, Liu D, Li Y, Wang A, Li W, Dong Y, Guo W. Exp Cell Res; 2020 May 01; 390(1):111939. PubMed ID: 32142853 [Abstract] [Full Text] [Related]
18. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway. Shen T, Yang Z, Cheng X, Xiao Y, Yu K, Cai X, Xia C, Li Y. Oncol Rep; 2017 Apr 01; 37(4):2095-2100. PubMed ID: 28259918 [Abstract] [Full Text] [Related]
19. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway. Wei S, Wang L, Zhang L, Li B, Li Z, Zhang Q, Wang J, Chen L, Sun G, Li Q, Xu H, Zhang D, Xu Z. Tumour Biol; 2016 Sep 01; 37(9):12813-12821. PubMed ID: 27449034 [Abstract] [Full Text] [Related]
20. MicroRNA-760 inhibits the biological progression of colorectal carcinoma by directly targeting FOXA1 and regulating epithelial-to-mesenchymal transition and PI3K/AKT signaling pathway. Cong K, Li CG, Wei YH, Zhang K, Xu HB. Eur Rev Med Pharmacol Sci; 2019 Jul 01; 23(13):5730-5740. PubMed ID: 31298352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]